Bio-Rad executives were disinterested in conducting robust training in the Federal Corrupt Practices Act and shut down his efforts to report suspected violations, Sanford Wadler testified Wednesday in his whistleblower retaliation trial.
- Paul McCartney Tries to Avoid Duran Duran's Copyright Fate
- Ex-Clinton Aide Joins Boies Schiller in Silicon Valley
- With Oracle Bias Suit, Tech Firms Feel Labor Dept.'s Unwelcome Gaze
- Viewpoint: How Persky Case Shows the Need for More Data on Judicial Decision-Making
- In 'Slants' Case, Justices Skeptical of Ban on Disparaging Trademarks
- 2 Cases That Shine a Light on Judge Henderson's Legacy
A Q&A with James Burling, litigation director at the Pacific Legal Foundation, on what the change of administration means for the libertarian-leaning organization.
Goodwin Procter partner Elaine Herrmann Blais discusses the biologics case that's expected to reach the Supreme Court and why a repeal of the Affordable Care Act could have unwelcome ripple effects.
An employer's decision not to pursue a candidate is almost always final, but there are scenarios where a candidacy can be brought back to life.
When not handled properly, the selection and use of consultants and experts can create unnecessary risks for attorneys and clients.